Larimar Therapeutics
LRMR
LRMR
65 hedge funds and large institutions have $153M invested in Larimar Therapeutics in 2023 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 18 increasing their positions, 24 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 8
0.67% less ownership
Funds ownership: 90.2% → 89.52% (-0.67%)
25% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 24
Holders
65
Holding in Top 10
2
Calls
$121K
Puts
$3K
Top Buyers
| 1 | +$4.01M | |
| 2 | +$2.7M | |
| 3 | +$2.07M | |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
+$726K |
| 5 |
BFM
Boothbay Fund Management
New York
|
+$581K |
Top Sellers
| 1 | -$3.84M | |
| 2 | -$2.14M | |
| 3 | -$1.52M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$800K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$780K |